{"entity":{"type":"insider","cik":"0001796226","url":"/insider/0001796226","json_url":"/insider/0001796226.json","name":"MURPHY ANDREW J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":209,"n_filings":14,"first":"2020-01-28","last":"2024-08-15","span_basis":"filed_date"},"name_variants":[{"name":"MURPHY ANDREW J","source":"filing","n_filings":14,"first_seen":"2020-01-28","last_seen":"2024-08-15"}],"transactions":[{"id":2715835,"accession":"0001968202-24-000119","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-20","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1016.0,"shares_display":"1,016","price_per_share":1156.43,"price_display":"1,156.43","price_state":"stated","total_value":1174932.88,"total_display":"1,174,932.88","shares_owned_after":49004.0,"shares_owned_after_display":"49,004","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715829,"accession":"0001968202-24-000119","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-19","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":987.0,"shares_display":"987","price_per_share":1153.74,"price_display":"1,153.74","price_state":"stated","total_value":1138741.38,"total_display":"1,138,741.38","shares_owned_after":51199.0,"shares_owned_after_display":"51,199","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715825,"accession":"0001968202-24-000119","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-18","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":844.0,"shares_display":"844","price_per_share":1150.41,"price_display":"1,150.41","price_state":"stated","total_value":970946.04,"total_display":"970,946.04","shares_owned_after":52568.0,"shares_owned_after_display":"52,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715819,"accession":"0001968202-24-000119","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-17","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":777.0,"shares_display":"777","price_per_share":1154.66,"price_display":"1,154.66","price_state":"stated","total_value":897170.82,"total_display":"897,170.82","shares_owned_after":50422.0,"shares_owned_after_display":"50,422","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715815,"accession":"0001968202-24-000119","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-16","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":537.0,"shares_display":"537","price_per_share":1148.52,"price_display":"1,148.52","price_state":"stated","total_value":616755.24,"total_display":"616,755.24","shares_owned_after":53706.0,"shares_owned_after_display":"53,706","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715797,"accession":"0001968202-24-000119","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-15","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":402.0,"shares_display":"402","price_per_share":1155.76,"price_display":"1,155.76","price_state":"stated","total_value":464615.52,"total_display":"464,615.52","shares_owned_after":50020.0,"shares_owned_after_display":"50,020","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715791,"accession":"0001968202-24-000119","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-14","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":331.0,"shares_display":"331","price_per_share":1159.69,"price_display":"1,159.69","price_state":"stated","total_value":383857.39,"total_display":"383,857.39","shares_owned_after":48306.0,"shares_owned_after_display":"48,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715788,"accession":"0001968202-24-000119","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-13","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":294.0,"shares_display":"294","price_per_share":1149.6,"price_display":"1,149.60","price_state":"stated","total_value":337982.4,"total_display":"337,982.40","shares_owned_after":53412.0,"shares_owned_after_display":"53,412","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715784,"accession":"0001968202-24-000119","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-12","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":197.0,"shares_display":"197","price_per_share":1152.36,"price_display":"1,152.36","price_state":"stated","total_value":227014.92,"total_display":"227,014.92","shares_owned_after":52186.0,"shares_owned_after_display":"52,186","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715780,"accession":"0001968202-24-000119","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-11","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":189.0,"shares_display":"189","price_per_share":1158.78,"price_display":"1,158.78","price_state":"stated","total_value":219009.42,"total_display":"219,009.42","shares_owned_after":48637.0,"shares_owned_after_display":"48,637","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715777,"accession":"0001968202-24-000119","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":185.0,"shares_display":"185","price_per_share":1151.46,"price_display":"1,151.46","price_state":"stated","total_value":213020.1,"total_display":"213,020.10","shares_owned_after":52383.0,"shares_owned_after_display":"52,383","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715773,"accession":"0001968202-24-000119","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-9","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":178.0,"shares_display":"178","price_per_share":1157.41,"price_display":"1,157.41","price_state":"stated","total_value":206018.98,"total_display":"206,018.98","shares_owned_after":48826.0,"shares_owned_after_display":"48,826","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715768,"accession":"0001968202-24-000119","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-8","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":148.0,"shares_display":"148","price_per_share":1145.58,"price_display":"1,145.58","price_state":"stated","total_value":169545.84,"total_display":"169,545.84","shares_owned_after":54294.0,"shares_owned_after_display":"54,294","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715764,"accession":"0001968202-24-000119","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-7","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79.0,"shares_display":"79","price_per_share":1143.28,"price_display":"1,143.28","price_state":"stated","total_value":90319.12,"total_display":"90,319.12","shares_owned_after":54487.0,"shares_owned_after_display":"54,487","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715760,"accession":"0001968202-24-000119","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-6","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55.0,"shares_display":"55","price_per_share":1140.31,"price_display":"1,140.31","price_state":"stated","total_value":62717.05,"total_display":"62,717.05","shares_owned_after":54614.0,"shares_owned_after_display":"54,614","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715756,"accession":"0001968202-24-000119","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":51.0,"shares_display":"51","price_per_share":1146.6,"price_display":"1,146.60","price_state":"stated","total_value":58476.6,"total_display":"58,476.60","shares_owned_after":54243.0,"shares_owned_after_display":"54,243","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715752,"accession":"0001968202-24-000119","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":48.0,"shares_display":"48","price_per_share":1142.94,"price_display":"1,142.94","price_state":"stated","total_value":54861.12,"total_display":"54,861.12","shares_owned_after":54566.0,"shares_owned_after_display":"54,566","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2715745,"accession":"0001968202-24-000119","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001968202-24-000119","line_url":"/filing/0001968202-24-000119#line-3","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45.0,"shares_display":"45","price_per_share":1144.89,"price_display":"1,144.89","price_state":"stated","total_value":51520.05,"total_display":"51,520.05","shares_owned_after":54442.0,"shares_owned_after_display":"54,442","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-14","filed_date":"2024-08-15","scope":"insider"},{"id":2167161,"accession":"0001968202-24-000086","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-16","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1108.0,"shares_display":"1,108","price_per_share":956.34,"price_display":"956.34","price_state":"stated","total_value":1059624.72,"total_display":"1,059,624.72","shares_owned_after":50364.0,"shares_owned_after_display":"50,364","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167159,"accession":"0001968202-24-000086","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-15","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":870.0,"shares_display":"870","price_per_share":954.66,"price_display":"954.66","price_state":"stated","total_value":830554.2,"total_display":"830,554.20","shares_owned_after":52017.0,"shares_owned_after_display":"52,017","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167158,"accession":"0001968202-24-000086","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-14","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":730.0,"shares_display":"730","price_per_share":957.35,"price_display":"957.35","price_state":"stated","total_value":698865.5,"total_display":"698,865.50","shares_owned_after":49634.0,"shares_owned_after_display":"49,634","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167157,"accession":"0001968202-24-000086","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-13","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":576.0,"shares_display":"576","price_per_share":953.77,"price_display":"953.77","price_state":"stated","total_value":549371.52,"total_display":"549,371.52","shares_owned_after":52887.0,"shares_owned_after_display":"52,887","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167152,"accession":"0001968202-24-000086","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-12","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":545.0,"shares_display":"545","price_per_share":955.54,"price_display":"955.54","price_state":"stated","total_value":520769.3,"total_display":"520,769.30","shares_owned_after":51472.0,"shares_owned_after_display":"51,472","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167143,"accession":"0001968202-24-000086","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-11","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":512.0,"shares_display":"512","price_per_share":959.36,"price_display":"959.36","price_state":"stated","total_value":491192.32,"total_display":"491,192.32","shares_owned_after":48645.0,"shares_owned_after_display":"48,645","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167137,"accession":"0001968202-24-000086","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":477.0,"shares_display":"477","price_per_share":958.34,"price_display":"958.34","price_state":"stated","total_value":457128.18,"total_display":"457,128.18","shares_owned_after":49157.0,"shares_owned_after_display":"49,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167133,"accession":"0001968202-24-000086","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-9","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":444.0,"shares_display":"444","price_per_share":952.4,"price_display":"952.40","price_state":"stated","total_value":422865.6,"total_display":"422,865.60","shares_owned_after":53463.0,"shares_owned_after_display":"53,463","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167131,"accession":"0001968202-24-000086","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-8","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":196.0,"shares_display":"196","price_per_share":968.2,"price_display":"968.20","price_state":"stated","total_value":189767.2,"total_display":"189,767.20","shares_owned_after":48306.0,"shares_owned_after_display":"48,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167127,"accession":"0001968202-24-000086","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-7","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":182.0,"shares_display":"182","price_per_share":951.92,"price_display":"951.92","price_state":"stated","total_value":173249.44,"total_display":"173,249.44","shares_owned_after":53907.0,"shares_owned_after_display":"53,907","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167123,"accession":"0001968202-24-000086","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-6","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78.0,"shares_display":"78","price_per_share":965.51,"price_display":"965.51","price_state":"stated","total_value":75309.78,"total_display":"75,309.78","shares_owned_after":48519.0,"shares_owned_after_display":"48,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167119,"accession":"0001968202-24-000086","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47.0,"shares_display":"47","price_per_share":961.74,"price_display":"961.74","price_state":"stated","total_value":45201.78,"total_display":"45,201.78","shares_owned_after":48598.0,"shares_owned_after_display":"48,598","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167115,"accession":"0001968202-24-000086","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17.0,"shares_display":"17","price_per_share":966.3,"price_display":"966.30","price_state":"stated","total_value":16427.1,"total_display":"16,427.10","shares_owned_after":48502.0,"shares_owned_after_display":"48,502","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":2167113,"accession":"0001968202-24-000086","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001968202-24-000086","line_url":"/filing/0001968202-24-000086#line-3","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1.0,"shares_display":"1","price_per_share":962.87,"price_display":"962.87","price_state":"stated","total_value":962.87,"total_display":"962.87","shares_owned_after":48597.0,"shares_owned_after_display":"48,597","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-14","filed_date":"2024-03-15","scope":"insider"},{"id":8241741,"accession":"0001968202-23-000046","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-14","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1881.0,"shares_display":"1,881","price_per_share":817.36,"price_display":"817.36","price_state":"stated","total_value":1537454.16,"total_display":"1,537,454.16","shares_owned_after":62256.0,"shares_owned_after_display":"62,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241737,"accession":"0001968202-23-000046","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-13","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1333.0,"shares_display":"1,333","price_per_share":818.59,"price_display":"818.59","price_state":"stated","total_value":1091180.47,"total_display":"1,091,180.47","shares_owned_after":60923.0,"shares_owned_after_display":"60,923","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241734,"accession":"0001968202-23-000046","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-12","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":973.0,"shares_display":"973","price_per_share":819.57,"price_display":"819.57","price_state":"stated","total_value":797441.61,"total_display":"797,441.61","shares_owned_after":59950.0,"shares_owned_after_display":"59,950","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241730,"accession":"0001968202-23-000046","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-11","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":829.0,"shares_display":"829","price_per_share":816.46,"price_display":"816.46","price_state":"stated","total_value":676845.34,"total_display":"676,845.34","shares_owned_after":64137.0,"shares_owned_after_display":"64,137","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241728,"accession":"0001968202-23-000046","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":372.0,"shares_display":"372","price_per_share":812.57,"price_display":"812.57","price_state":"stated","total_value":302276.04,"total_display":"302,276.04","shares_owned_after":65346.0,"shares_owned_after_display":"65,346","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241726,"accession":"0001968202-23-000046","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-9","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":345.0,"shares_display":"345","price_per_share":820.54,"price_display":"820.54","price_state":"stated","total_value":283086.3,"total_display":"283,086.30","shares_owned_after":59605.0,"shares_owned_after_display":"59,605","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241724,"accession":"0001968202-23-000046","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-8","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":184.0,"shares_display":"184","price_per_share":821.46,"price_display":"821.46","price_state":"stated","total_value":151148.64,"total_display":"151,148.64","shares_owned_after":59421.0,"shares_owned_after_display":"59,421","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241721,"accession":"0001968202-23-000046","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-7","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":167.0,"shares_display":"167","price_per_share":813.66,"price_display":"813.66","price_state":"stated","total_value":135881.22,"total_display":"135,881.22","shares_owned_after":65179.0,"shares_owned_after_display":"65,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241719,"accession":"0001968202-23-000046","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-6","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":155.0,"shares_display":"155","price_per_share":815.97,"price_display":"815.97","price_state":"stated","total_value":126475.35,"total_display":"126,475.35","shares_owned_after":64966.0,"shares_owned_after_display":"64,966","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241717,"accession":"0001968202-23-000046","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-5","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":136.0,"shares_display":"136","price_per_share":810.38,"price_display":"810.38","price_state":"stated","total_value":110211.68,"total_display":"110,211.68","shares_owned_after":65821.0,"shares_owned_after_display":"65,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241715,"accession":"0001968202-23-000046","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-4","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":103.0,"shares_display":"103","price_per_share":811.37,"price_display":"811.37","price_state":"stated","total_value":83571.11,"total_display":"83,571.11","shares_owned_after":65718.0,"shares_owned_after_display":"65,718","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8241712,"accession":"0001968202-23-000046","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001968202-23-000046","line_url":"/filing/0001968202-23-000046#line-3","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":58.0,"shares_display":"58","price_per_share":814.06,"price_display":"814.06","price_state":"stated","total_value":47215.48,"total_display":"47,215.48","shares_owned_after":65121.0,"shares_owned_after_display":"65,121","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-05","filed_date":"2023-12-06","scope":"insider"},{"id":8653131,"accession":"0001968202-23-000042","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001968202-23-000042","line_url":"/filing/0001968202-23-000042#line-13","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1614.0,"shares_display":"1,614","price_per_share":798.63,"price_display":"798.63","price_state":"stated","total_value":1288988.82,"total_display":"1,288,988.82","shares_owned_after":62996.0,"shares_owned_after_display":"62,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-15","scope":"insider"},{"id":8653129,"accession":"0001968202-23-000042","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001968202-23-000042","line_url":"/filing/0001968202-23-000042#line-12","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1601.0,"shares_display":"1,601","price_per_share":799.48,"price_display":"799.48","price_state":"stated","total_value":1279967.48,"total_display":"1,279,967.48","shares_owned_after":61395.0,"shares_owned_after_display":"61,395","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-15","scope":"insider"},{"id":8653127,"accession":"0001968202-23-000042","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001968202-23-000042","line_url":"/filing/0001968202-23-000042#line-11","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":877.0,"shares_display":"877","price_per_share":801.56,"price_display":"801.56","price_state":"stated","total_value":702968.12,"total_display":"702,968.12","shares_owned_after":60136.0,"shares_owned_after_display":"60,136","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-15","scope":"insider"},{"id":8653125,"accession":"0001968202-23-000042","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001968202-23-000042","line_url":"/filing/0001968202-23-000042#line-10","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":752.0,"shares_display":"752","price_per_share":794.57,"price_display":"794.57","price_state":"stated","total_value":597516.64,"total_display":"597,516.64","shares_owned_after":65161.0,"shares_owned_after_display":"65,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-15","scope":"insider"},{"id":8653124,"accession":"0001968202-23-000042","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001968202-23-000042","line_url":"/filing/0001968202-23-000042#line-9","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":382.0,"shares_display":"382","price_per_share":800.55,"price_display":"800.55","price_state":"stated","total_value":305810.1,"total_display":"305,810.10","shares_owned_after":61013.0,"shares_owned_after_display":"61,013","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-15","scope":"insider"},{"id":8653122,"accession":"0001968202-23-000042","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001968202-23-000042","line_url":"/filing/0001968202-23-000042#line-8","is_derivative":false,"issuer_cik":"0000872589","issuer_name":"REGENERON PHARMACEUTICALS, INC.","issuer_ticker":"REGN","issuer_name_source":null,"issuer_url":"/issuer/0000872589","owner_cik":"0001796226","owner_name":"MURPHY ANDREW J","owner_url":"/insider/0001796226","role":"Officer (EVP Research)","officer_title":"EVP Research","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":347.0,"shares_display":"347","price_per_share":802.63,"price_display":"802.63","price_state":"stated","total_value":278512.61,"total_display":"278,512.61","shares_owned_after":59789.0,"shares_owned_after_display":"59,789","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-14","filed_date":"2023-11-15","scope":"insider"}],"next_cursor":"2023-11-14|8653122","ledger_fault":false,"count":{"value":209,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":209,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":209},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000872589","name":"REGENERON PHARMACEUTICALS, INC.","url":"/issuer/0000872589","role":"Officer (EVP Research)","n_filings":14,"first_seen":"2020-01-28","last_seen":"2024-08-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001796226","retrieved_at":"2026-08-22T00:37:19+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}